Patents Examined by Erin M Bowers
  • Patent number: 8530202
    Abstract: A method for manufacturing a linear-chain beta-1,3-glucan is disclosed that comprises polymerizing glucose-1-phosphate serving as a substrate by contacting the glucose-1-phosphate with a beta-1,3-glucan phosphorylase derived from a species in the genus Ochromonas. A laminarioligosaccharide may be added to serve as a primer. A linear-chain beta-1,3-glucan having a degree of polymerization between about 30 to 70 is also disclosed.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: September 10, 2013
    Assignee: Mie University
    Inventors: Naoto Isono, Yutaka Yamamoto, Wataru Saburi
  • Patent number: 8507239
    Abstract: Provided is a methylation-specific restriction endonuclease for a DNA duplex substrate, which endonuclease recognizes in a strand of the duplex a 2 to 6 nucleotide recognition sequence comprising a 5-methylcytosine, and cleaves each strand of the duplex at a fixed position outside the recognition sequence.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: August 13, 2013
    Assignee: Fermentas UAB
    Inventors: Arvydas Lubys, Jolanta Vitkute, Judita Lubiene, Arvydas Janulaitis
  • Patent number: 8501457
    Abstract: A medium for enriching Listeria spp. without polymerase chain reaction (PCR) inhibition and a method of using the medium.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: August 6, 2013
    Assignee: Samsung Techwin Co., Ltd.
    Inventors: Jun Li, Win Den Cheung
  • Patent number: 8486672
    Abstract: To provide a method for supplying lauric acid with algae. The method for producing an oil or fat containing lauric acid as a constituent fatty acid includes culturing algae in the class Chlorarachniophyceae in a medium and recovering, from the culture product, an oil or fat having a lauric acid content of 3 weight % or higher of the fatty acid composition.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: July 16, 2013
    Assignee: Kao Corporation
    Inventors: Hiroshi Yoshida, Fumikazu Takahashi, Yasushi Takimura
  • Patent number: 8470597
    Abstract: A composite comprising a stem cell; a biodegradable layer, which can provide an environment for the stem cell to grow and to differentiate, and; a N-isopropylacrylamide (NIPAAm), which can polymerize with the biodegradable layer and possess the temperature-responsive character for easy stripping. The present invention further provides a method for treating a patient with a skin defect, consisting of (a) providing said patient with a composite consisting of a N-isopropylacrylamide (NIPAAm) layer polymerized with a biodegradable layer containing gelatin and a layer of polypropylene (PP) non-woven, wherein a bone marrow derived mononuclear cell with CD45 negative and glycophorin A negative is cultivating on the biodegradable layer; (b) covering said composite on the skin defect of the patient; and (c) treating the composite with water below 25° C. to strip off the layer of polypropylene (PP) non-woven.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: June 25, 2013
    Assignee: Taipei Veterans General Hospital
    Inventors: Shih-Hwa Chiou, Cherng-Kang Perng, Han-Tzo Lin, Yi-Ping Yang
  • Patent number: 8465966
    Abstract: The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: June 18, 2013
    Assignee: University of South Florida
    Inventor: Matt Ewert
  • Patent number: 8349376
    Abstract: A novel dietary supplement is featured which can benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, dementia/Alzheimer's disease, high blood pressure, high cholesterol, coronary artery disease, stroke and mental cognition.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: January 8, 2013
    Inventor: Mark S. Bezzek